NL7514627A - PROCEDURE FOR IMPROVING THE INTRAVENOUS TOLERABILITY OF GAMMAGLOBULINS. - Google Patents

PROCEDURE FOR IMPROVING THE INTRAVENOUS TOLERABILITY OF GAMMAGLOBULINS.

Info

Publication number
NL7514627A
NL7514627A NL7514627A NL7514627A NL7514627A NL 7514627 A NL7514627 A NL 7514627A NL 7514627 A NL7514627 A NL 7514627A NL 7514627 A NL7514627 A NL 7514627A NL 7514627 A NL7514627 A NL 7514627A
Authority
NL
Netherlands
Prior art keywords
gammaglobulins
improving
procedure
tolerability
intravenous
Prior art date
Application number
NL7514627A
Other languages
Dutch (nl)
Other versions
NL179824C (en
NL179824B (en
Original Assignee
Ratiopharma Anstalt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ratiopharma Anstalt filed Critical Ratiopharma Anstalt
Publication of NL7514627A publication Critical patent/NL7514627A/en
Publication of NL179824B publication Critical patent/NL179824B/en
Application granted granted Critical
Publication of NL179824C publication Critical patent/NL179824C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NLAANVRAGE7514627,A 1975-01-02 1975-12-16 METHOD FOR EXTRACTING INTRAVENOUSLY TOLERABLE GAMMAGLOBULINS. NL179824C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2500076A DE2500076C3 (en) 1975-01-02 1975-01-02 Process for the production of intravenously tolerated gamma globulins

Publications (3)

Publication Number Publication Date
NL7514627A true NL7514627A (en) 1976-07-06
NL179824B NL179824B (en) 1986-06-16
NL179824C NL179824C (en) 1986-11-17

Family

ID=5935911

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7514627,A NL179824C (en) 1975-01-02 1975-12-16 METHOD FOR EXTRACTING INTRAVENOUSLY TOLERABLE GAMMAGLOBULINS.

Country Status (20)

Country Link
JP (1) JPS5512001B2 (en)
AT (1) AT344883B (en)
AU (1) AU505416B2 (en)
BE (1) BE837211A (en)
CA (1) CA1058075A (en)
DD (1) DD121875A5 (en)
DE (1) DE2500076C3 (en)
DK (1) DK144679C (en)
EG (1) EG11987A (en)
ES (1) ES443982A1 (en)
FR (1) FR2296429A1 (en)
GB (1) GB1495159A (en)
IE (1) IE43449B1 (en)
IL (1) IL48766A (en)
IN (1) IN143525B (en)
NL (1) NL179824C (en)
PL (1) PL99599B1 (en)
SE (1) SE437470B (en)
SU (1) SU576898A3 (en)
ZA (1) ZA758050B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2604759C2 (en) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Method of Obtaining IV Compatible Gamma Globulins
JPS6016406B2 (en) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル Method for producing intravenously administrable gamma globulin and gamma globulin prepared thereby
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
GB1603244A (en) * 1977-05-20 1981-11-18 Max Planck Gesellschaft Medicaments for the suppression of pathological processes
JPS5822085B2 (en) * 1977-07-19 1983-05-06 株式会社ミドリ十字 Intravenous gamma globulin preparations
AT359641B (en) * 1978-09-19 1980-11-25 Immuno Ag METHOD FOR PRODUCING AN INTRAVENOUS ADMINISTRABLE ANTIBODY-CONTAINING IMMUNOGLOBULIN PREPARATE
EP0019403B1 (en) * 1979-05-10 1985-07-31 American Hospital Supply Corporation Hydroxyalkyl-starch drug carrier
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
EP0085747B2 (en) * 1982-02-08 1990-05-30 Schweizerisches Serum- und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten Intravenously administrable human immunoglobuline and process for its preparation
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
SE8302483L (en) * 1983-05-02 1984-11-03 Pharmacia Ind PROCEDURE FOR PURIFICATION OF BIOLOGICALLY ACTIVE SUBSTANCES
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
DE19907257A1 (en) * 1999-02-21 2000-09-14 Bernd Horst Meier Means for controlling the diffusion of injection solutions
DE10040707A1 (en) * 2000-08-17 2002-03-14 Braun Melsungen Ag Injectable aqueous medicament, containing colloid, e.g. hydroxyethyl starch, to modulate mobility, diffusion, pharmacokinetic and electrophoretic properties of active agent and improve effectiveness
DE10303974A1 (en) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid β (1-42) oligomers, process for their preparation and their use
PT2289909E (en) 2005-11-30 2015-02-10 Abbvie Inc Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies
KR20140087058A (en) 2005-11-30 2014-07-08 애브비 인코포레이티드 Monoclonal antibodies against amyloid beta protein and uses thereof
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US20100311767A1 (en) 2007-02-27 2010-12-09 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
ES2684475T3 (en) 2010-04-15 2018-10-03 Abbvie Inc. Proteins that bind to beta amyloid
MX358739B (en) 2010-08-14 2018-09-03 Abbvie Inc Star Amyloid-beta binding proteins.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE348942B (en) * 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
DE2234069A1 (en) * 1971-07-16 1973-02-08 South African Inventions METHOD OF MANUFACTURING A PURIFIED GAMMA GLOBULIN
IL43643A (en) * 1972-11-27 1976-10-31 Baxter Laboratories Inc Method for production of gamma globulin
JPS49101516A (en) * 1973-01-13 1974-09-25

Also Published As

Publication number Publication date
JPS5191321A (en) 1976-08-10
IE43449B1 (en) 1981-02-25
ATA981675A (en) 1977-12-15
DE2500076C3 (en) 1982-11-18
IL48766A0 (en) 1976-02-29
IN143525B (en) 1977-12-17
EG11987A (en) 1981-12-31
DK144679C (en) 1982-10-11
AU505416B2 (en) 1979-11-22
ES443982A1 (en) 1977-07-16
IE43449L (en) 1976-07-02
DD121875A5 (en) 1976-09-05
ZA758050B (en) 1976-12-29
BE837211A (en) 1976-06-30
SU576898A3 (en) 1977-10-15
IL48766A (en) 1979-11-30
SE7514388L (en) 1976-07-05
CA1058075A (en) 1979-07-10
GB1495159A (en) 1977-12-14
FR2296429B1 (en) 1978-12-01
AT344883B (en) 1978-08-10
NL179824C (en) 1986-11-17
DK584375A (en) 1976-07-03
DK144679B (en) 1982-05-10
SE437470B (en) 1985-03-04
JPS5512001B2 (en) 1980-03-29
DE2500076A1 (en) 1976-07-08
PL99599B1 (en) 1978-07-31
FR2296429A1 (en) 1976-07-30
DE2500076B2 (en) 1979-02-22
AU8792175A (en) 1977-07-14
NL179824B (en) 1986-06-16

Similar Documents

Publication Publication Date Title
NL7514627A (en) PROCEDURE FOR IMPROVING THE INTRAVENOUS TOLERABILITY OF GAMMAGLOBULINS.
NL7603223A (en) PROCEDURE FOR THE CONTINUOUS PREPARATION OF POLYBUTLENE ETERPHALATES.
NL183183C (en) PROCESS FOR THE PREPARATION OF POLYETHYLENE POLYAMINS.
NL7613094A (en) PROCEDURE FOR THE CONTINUOUS PREPARATION OF HIGH MOLECULAR POLYETHENTIC FREEDOMATE.
NL190721C (en) Process for the preparation of 3-hydroxy-cephem derivatives.
NL7610632A (en) PROCESS FOR THE PREPARATION OF OLEFINS.
NL7606343A (en) PROCESS FOR THE PREPARATION OF OXYGEN EXCLUDING ADHESIVES OR SEALING AGENTS.
NL7600163A (en) PROCEDURE FOR CARBONYLING ARYLALKYLHALOGENIDES.
NL7613431A (en) PROCESS FOR THE PREPARATION OF O-HYDROXYBENZALDEHYDEN.
NL7608674A (en) PROCESS FOR THE PREPARATION OF CANTHAXANTHINE.
NL7610066A (en) PROCESS FOR THE PREPARATION OF AMIDOXIM DERIBASES.
NL7606994A (en) PROCESS FOR THE PREPARATION OF ACYLCYANIDES.
NL7603935A (en) PROCESS FOR THE PREPARATION OF HALOGENATED HYDROCARBONS.
NL7605411A (en) PROCEDURE FOR PREPARING THE ANTIBIOTIC LUCKNOMYCIN.
NL7700975A (en) METHOD OF INCREASING THE INTRAVENOUS TOLERABILITY OF GLOBULINE.
NL7605786A (en) PROCESS FOR THE PREPARATION OF COPOLYMERS OF ETHENE.
NL7609939A (en) PROCESS FOR THE PREPARATION OF N-ACYLHYDROXYARYL GLYCINS.
NL7600512A (en) PROCESS FOR THE PREPARATION OF 2-AMINOBUTANOL-1.
NL7611424A (en) PROCESS FOR THE PREPARATION OF ETHYLVANADATE.
NL7608221A (en) METHOD OF PREVENTING THE DEPOSITION OF BOILESTONE.
NL184952C (en) PROCESS FOR THE PREPARATION OF CYCLOHEXANONOXIM.
NL7607505A (en) PROCESS FOR THE PREPARATION OF SULFAMYL-BENZYL-AMINES.
NL7611271A (en) PROCESS FOR THE PREPARATION OF 4-ALKYLTHIO-SEMICARBAZIDES.
NL7610697A (en) PROCEDURE FOR RECOVERY OF PROPERTIES.
NL186160C (en) PROCESS FOR THE PREPARATION OF THEASPIRAN.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: ARMOUR PHARMACEUTICAL COMPANY

A85 Still pending on 85-01-01
V1 Lapsed because of non-payment of the annual fee